diabetes mellitus type 2/seizures

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

12 niðurstöður

Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Severe obesity, afflicting ~8% of adolescents in the U.S., is a serious and challenging medical and public health problem. The number and levels of cardiovascular risk factors are considerably higher in the context of severe obesity compared to milder forms of obesity. Approximately 85% of youth

Exercise Physiology Study

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Diabetes mellitus afflicts close to 10% of our population and 5% of those with diabetes have type 1, which is defined by an absolute deficiency of insulin. The need for managing diabetes is critical, given the economic burden of this disease, with over $175 billion dollars in direct health care

A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Background information It is well recognised that patients with both type 1 and type 2 diabetes suffering repeated hypoglycaemia are at risk of death and significant morbidity (1). This is of major clinical importance as currently, only the recording of a low blood sugar at the time of hypoglycaemia

The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Experimental Design: This Phase 2 study will be done prospectively and will be conducted in two stages. The initial stage will be the general study and the second stage will be the sub-study. We plan to screen up to 1,000 subjects. Our enrollment goal is 250 subjects total (with 50 subjects enrolled

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed bariatric procedures used in the treatment of severe obesity. RYGB has in several studies been shown to result in significant and sustained weight loss. Moreover, RYGB has a beneficial effect on obese subjects with type 2 diabetes

Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Topiramate in Adolescents With Severe Obesity

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The prevalence of severe pediatric obesity is on the rise and youth with this condition are at elevated risk for developing chronic diseases such as cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Lifestyle modification therapy alone is ineffective for most adolescents with severe

Bariatric Surgery and Reactive Hypoglycemia

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

INTRODUCTION Geltrude Mingrone,Simona Panunzi, Andrea De Gaetano, Caterina Guidone, Celestino Pio Lombardi, Marco Raffaelli,Rocco Bellantone Departments of Internal Medicine, Surgery and Biomathematics of the Catholic University of Rome, Italy The overall prevalence of grade 2 and 3 adult obesity

To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Patients with type 2 diabetes mellitus with and without diabetic nephropathy will be identified from clinical records and approached for their interest in participating in the study. Written informed consent will be obtained from patients who qualify according to the eligibility criteria and agree

PIoglitazone for PrEvention of Restenosis in Diabetic Patients

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

2.Design This is a randomised, placebo-controlled, double-blinded, multicenter centre study.The patients' clinical data will be recorded on case report forms (CRF). 3.Aim of the study To evaluate the efficacy of Pioglitazone (30 mg/daily) therapy on in-stent late luminal loss in T2DM patients

Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Specific Aims: This study is a six-week, open label trial of the novel antipsychotic agent, ziprasidone, added to a stable dose of clozapine or olanzapine in 40 diabetes mellitus patients, patients with an impaired fasting glucose or insulin resistance with schizophrenia or schizoaffective

A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Topiramate is a medication for the treatment of seizures, but not approved for the treatment of obesity. This is a randomized, double-blind, placebo controlled study to evaluate the effectiveness and safety of topiramate in Type 2 diabetic patients with obesity who have failed on treatment with

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum